TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis
Clinical trial NCT04589260 · TERMINATED
Trial details
- NCT number
- NCT04589260
- Sponsor
- Theravance Biopharma
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2021-05-06
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.